Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of oncology, 2019-12, Vol.30 (12), p.1856-1883 [Peer Reviewed Journal]ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz400 ;PMID: 31549998Full text available |
|
2 |
Material Type: Article
|
Active Surveillance for T1bN0M0 Papillary Thyroid CarcinomaThyroid (New York, N.Y.), 2019-01, Vol.29 (1), p.59-63 [Peer Reviewed Journal]2019, Mary Ann Liebert, Inc., publishers ;ISSN: 1050-7256 ;EISSN: 1557-9077 ;DOI: 10.1089/thy.2018.0462 ;PMID: 30560718Full text available |
|
3 |
Material Type: Article
|
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancerAnnals of oncology, 2022-07, Vol.33 (7), p.674-684 [Peer Reviewed Journal]2022 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2022.04.009 ;PMID: 35491008Full text available |
|
4 |
Material Type: Article
|
Update on Fundamental Mechanisms of Thyroid CancerFrontiers in endocrinology (Lausanne), 2020-03, Vol.11, p.102-102 [Peer Reviewed Journal]Copyright © 2020 Prete, Borges de Souza, Censi, Muzza, Nucci and Sponziello. ;COPYRIGHT 2020 Frontiers Research Foundation ;Copyright © 2020 Prete, Borges de Souza, Censi, Muzza, Nucci and Sponziello. 2020 Prete, Borges de Souza, Censi, Muzza, Nucci and Sponziello ;ISSN: 1664-2392 ;EISSN: 1664-2392 ;DOI: 10.3389/fendo.2020.00102 ;PMID: 32231639Full text available |
|
5 |
Material Type: Article
|
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersThe journal of clinical endocrinology and metabolism, 2019-05, Vol.104 (5), p.1417-1428 [Peer Reviewed Journal]Copyright © 2019 Endocrine Society 2019 ;Copyright © Oxford University Press 2015 ;Copyright © 2019 Endocrine Society. ;COPYRIGHT 2019 Oxford University Press ;Copyright © 2019 Endocrine Society ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2018-01478 ;PMID: 30256977Full text available |
|
6 |
Material Type: Article
|
Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future ProspectsThyroid (New York, N.Y.), 2019-03, Vol.29 (3), p.311-321 [Peer Reviewed Journal]2019, Mary Ann Liebert, Inc., publishers ;Copyright 2019, Mary Ann Liebert, Inc., publishers 2019 ;ISSN: 1050-7256 ;EISSN: 1557-9077 ;DOI: 10.1089/thy.2018.0509 ;PMID: 30747050Full text available |
|
7 |
Material Type: Article
|
OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAPOncogene, 2021-07, Vol.40 (30), p.4859-4871 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;ISSN: 0950-9232 ;EISSN: 1476-5594 ;DOI: 10.1038/s41388-021-01901-7 ;PMID: 34155345Full text available |
|
8 |
Material Type: Article
|
Effect of hypoxia-HIF-1[alpha]-periostin axis in thyroid cancerOncology reports, 2024-03, Vol.51 (4), p.1COPYRIGHT 2024 Spandidos Publications ;ISSN: 1021-335X ;EISSN: 1791-2431 ;DOI: 10.3892/or.2024.8716Full text available |
|
9 |
Material Type: Article
|
The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the ReclassificationThyroid (New York, N.Y.), 2021-10, Vol.31 (10), p.152-1513 [Peer Reviewed Journal]2021, Mary Ann Liebert, Inc., publishers ;ISSN: 1050-7256 ;EISSN: 1557-9077 ;DOI: 10.1089/thy.2021.0158 ;PMID: 34060946Full text available |
|
10 |
Material Type: Article
|
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid CancerJournal of Nuclear Medicine, 2020-02, Vol.61 (2), p.177-182 [Peer Reviewed Journal]2020 by the Society of Nuclear Medicine and Molecular Imaging. ;Copyright Society of Nuclear Medicine Feb 1, 2020 ;2020 by the Society of Nuclear Medicine and Molecular Imaging. 2020 ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.119.227652 ;PMID: 31375570Full text available |
|
11 |
Material Type: Article
|
Immune and Inflammatory Cells in Thyroid Cancer MicroenvironmentInternational journal of molecular sciences, 2019-09, Vol.20 (18), p.4413 [Peer Reviewed Journal]2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 by the authors. 2019 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms20184413 ;PMID: 31500315Full text available |
|
12 |
Material Type: Article
|
Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative ReviewAdvances in therapy, 2020-07, Vol.37 (7), p.3112-3128 [Peer Reviewed Journal]The Author(s) 2020 ;ISSN: 0741-238X ;ISSN: 1865-8652 ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-020-01391-1Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptakeThe Journal of clinical investigation, 2021-09, Vol.131 (18), p.1-12 [Peer Reviewed Journal]COPYRIGHT 2021 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Sep 2021 ;2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI144847 ;PMID: 34237031Full text available |
|
14 |
Material Type: Article
|
Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid CancerInternational journal of molecular sciences, 2022-01, Vol.23 (2), p.699 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms23020699 ;PMID: 35054884Full text available |
|
15 |
Material Type: Article
|
The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid CancerWorld journal of surgery, 2020-05, Vol.44 (5), p.1506-1513 [Peer Reviewed Journal]Société Internationale de Chirurgie 2020 ;2020 The Author(s) under exclusive licence to Société Internationale de Chirurgie ;Société Internationale de Chirurgie 2020. ;ISSN: 0364-2313 ;EISSN: 1432-2323 ;DOI: 10.1007/s00268-019-05337-9 ;PMID: 31915977Full text available |
|
16 |
Material Type: Article
|
Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic ReviewThyroid (New York, N.Y.), 2020-11, Vol.30 (11), p.161-1612 [Peer Reviewed Journal]2020, Mary Ann Liebert, Inc., publishers ;ISSN: 1050-7256 ;EISSN: 1557-9077 ;DOI: 10.1089/thy.2019.0368 ;PMID: 32345152Full text available |
|
17 |
Material Type: Article
|
Sunitinib in the Treatment of Thyroid CancerCurrent medicinal chemistry, 2019-01, Vol.26 (6), p.963-972 [Peer Reviewed Journal]Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. ;Copyright Bentham Science Publishers Ltd. 2019 ;ISSN: 0929-8673 ;EISSN: 1875-533X ;DOI: 10.2174/0929867324666171006165942 ;PMID: 28990511Full text available |
|
18 |
Material Type: Article
|
Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995–2015)JNCI : Journal of the National Cancer Institute, 2020-08, Vol.112 (8), p.810-817 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press. 2019 ;The Author(s) 2019. Published by Oxford University Press. ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djz202 ;PMID: 31638139Full text available |
|
19 |
Material Type: Article
|
Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinomaCell death & disease, 2018-11, Vol.9 (11), p.1120-15, Article 1120 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-4889 ;EISSN: 2041-4889 ;DOI: 10.1038/s41419-018-1077-9 ;PMID: 30389909Full text available |
|
20 |
Material Type: Article
|
Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitorsNature communications, 2022-03, Vol.13 (1), p.1588-1588, Article 1588 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-29000-5 ;PMID: 35332119Full text available |